Cellda AB
Cellda AB is advancing cancer diagnostics with its cutting-edge Cellda® Image Analysis Suite, initially focusing on prostate cancer. Their technology aims to transform cancer diagnosis by providing faster, more accurate, and objective results, improving patient care and outcomes. The company is driven by a mission to redefine cancer diagnostics through digital pathology and computer-assisted analysis, reducing subjectivity and improving efficiency in healthcare. They have been in operation since 2018 and have secured 15 MSEK in capital.
Cellda AB
Cellda AB is advancing cancer diagnostics with its cutting-edge Cellda® Image Analysis Suite, initially focusing on prostate cancer. Their technology aims to transform cancer diagnosis by providing faster, more accurate, and objective results, improving patient care and outcomes. The company is driven by a mission to redefine cancer diagnostics through digital pathology and computer-assisted analysis, reducing subjectivity and improving efficiency in healthcare. They have been in operation since 2018 and have secured 15 MSEK in capital.